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Letter to the Editor
SIR,-We read with interest the letter by
Smith and Kundu (1976). Our work, using
3H-labelled adriamycin and digoxin, shows
results opposite to those reported.
Cats of either sex were lightly anaesthe-
tized, the chest rapidly opened, and the heart
quickly removed and suspended from an
Anderson Heart Perfusion System. The com-
position of the perfusion solution was (g/l)
NaCl 7-0, KCI 0-42, CaO2 0-24, MgCl2 0-2,
NaHCO3 2-1 and dextrose 1P8 with the
pH 735 and the temperature 38°C aerated
with 95% 02 and 5% CO2. The perfusion
pressure was constant at 50 cmH2O and the
heart rate was kept constant at 200 beats/min
using ventricular pacing.
Four groups were studied: [3H]digoxin
625 mg/l, [3H]digoxin 625 mg/l + adriamycin
10 mg/I, [3H]adriamycin 10 mg/l, and [3H]-
adriamycin 10 mg/l + digoxin 625 mg/l. The
myocardial content of [3H]digoxin was 2-32
± 0412 pmol/mg wet weight, while when
adriamycin was infused, the labelled content
of digoxin was 1-43 + 0 47 pmol/mg.
[3H]adriamycin content was 0-069 + 0-01
pmol/mg, and when adriamycin + digoxin
were infused simultaneously, the myocardial
adriamycin content was reduced to 0-025 +
0-01 pmol/mg.
Although the inhibition oflabelled digoxin
uptake by adriamycin is suggested, the
variance is too great for significance with a
sample size of 4 animals. However, the
inhibition ofuptake oflabelled adriamycin by
digoxin is significant (P < 0 05) in the 6
animals studied. Digoxin thus inhibits
adriamycin uptake acutely in the in vitro
Langendoff heart preparation. This obser-
vation combined with the initial work of
Arena et al. (1972) that strophanthin may
inhibit myocardial adriamycin uptake, makes
the inhibition of adriamycin uptake by
cardiac glycosides an area warranting further
study.
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